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Introduction 
Salmonella is a widespread pathogen that can infect a variety of animals, 
including man. Pork is considered, after eggs, the major source of infection in humans 
in the EU, with S. Typhimurium (ST), including monophasic strains (mST; S. 
1,4,[5],12:i- and S. 1,4,12:i-) being frequently implicated [1]. Reducing the prevalence 
of infected pigs on-farm contributes to minimising contamination of pig meat and edible 
offal for human consumption, as the slaughter process alone cannot cope with high 
levels of contamination. The persistent and frequently asymptomatic nature of porcine 
Salmonella infection, the organism’s colonisation of farm pests, such as rodents and 
wild birds, and ability to survive in the environment, means that effective control 
generally requires multiple measures [2]. It is generally accepted that vaccination can 
play a role in reducing the prevalence of Salmonella in pigs and could assist other on-
farm control measures by helping to prevent Salmonella colonizing the gut and reducing 
the subsequent shedding and development of a carrier state [3]. Several vaccines for 
Salmonella have been developed; from inactivated bacterins to elicit a humoral 
response, to live or adjuvanted vaccines that can stimulate cell-mediated immunity. A 
recent study examined the vaccination of sows in three farms with follow-up of the 
breeding and rearing animals for up to two years after the initial pre-vaccination visit 
[4]. The study provided evidence for sustained reductions of ST and mST-shedding 
among pigs up to slaughter age, although it was based on an uncontrolled observational 
field study. This project was tasked with investigating the effectiveness of sow 
vaccination with a live Salmonella Typhimurium vaccine by comparing results from 
eight indoor farrow-to-finish herds that were vaccinated and eight similar control herds. 
 
Material and methods 
Farms were selected based on the following inclusion criteria: (i) indoor breeder-
finisher enterprise, (ii) Herd size of 100-600 sows, (iii) a recent occurrence of ST or 
mST, (iv) presence of ST or mST in finishing pigs, (v) sows free of significant clinical 
disease which may have affected the efficacy of the vaccine. Herds were randomised 
into vaccinated (n=8) and non-vaccinated control groups (n=8). Herds were followed 
for approximately 69 weeks after the start of the trial, with four sampling visits. Sows 
were vaccinated with a live attenuated vaccine by subcutaneous injection (Salmoporc 
STM, IDT Biologika GmbH, Dessau-Rosslau, Germany). Vaccine was administered to 
pre-partum sows (6 weeks and 3 weeks ante-partum) with a single booster dose three 
weeks before each subsequent farrowing. The first dose was given to the first batch of 
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sows in week 1, with sampling visits taking place prior to vaccination (week 0); at a 
point when half of the progeny were estimated to originate from vaccinated sows (week 
21); when all of the finishers were from vaccinated sows (week 55); and a final 
sampling visit three to four months after visit 3 (week 69). 
A target of sixty individual floor faeces samples were collected at each visit from 
each of the following pig stages: weaners, growers, and finishers, providing a 95% 
probability of detection per group, assuming a 5% prevalence. In addition, pooled pen 
faeces samples (one or two pools per pen according to the number of pigs in the pen) 
were taken from the following pig stages: gestation, farrowing, weaners, growers, 
finishers and a combination of dry sows, gilts and boars. For each pig stage, up to a 
maximum of 20 pooled samples were collected per building and 60 per pig stage to 
ensure effective detection of Salmonella prevalence and diversity of serovars across the 
farm. In addition, wildlife and environmental samples (wildlife faeces, pooled water, 
etc) were collected at each visit. Material was cultured for Salmonella, using a 
modification of the ISO 6579:2002 (Annex D) method, as described previously [5]. 
Briefly, all pooled faeces samples (approximately 25 g) and swabs were pre-enriched in 
225 ml BPW at 37ºC for 18 h followed by enrichment in Modified Semi-Solid 
Rappaport-Vassiliadis medium (MRSV) for 24h and 48h at 41.5ºC then plating on 
Rambach agar which was incubated for 24h at 37°C. Sub-samples (2 g) of individual 
pig faeces samples were pre-enriched in 20 ml BPW and cultured as above. For 
Salmonella-positive individual faeces samples, a subset from each farm, building and 
epidemiological group sampled was subjected to a semi-quantitative enumeration 
procedure by creating a decimal dilution series in BPW immediately before pre-
enrichment. A selection (all isolates from pooled samples and individual samples that 
was cultured semi-quantitatively) of Salmonella isolates were serotyped using standard 
methodology. 
A mixed-effects logistic regression model was used to assess the effect of 
vaccination, to examine the association between time from the start of vaccination and 
the odds of a sample being Salmonella-positive. The a priori variables were pig stage 
from which the sample was collected (named pig type), sample type (individual or 
pooled) and sampling season (winter (Dec-Feb), spring (Mar-May), summer (Jun-Aug) 
and autumn (Sep-Nov)). The farm study identifier was added as a random effect to 
account for the non-independence of sample results from the same farm. An interaction 
term, including visit number and experimental group (vaccine or control), was added. 
Two outcomes were tested in the model: presence of all Salmonella or presence of only 
serovars of public health concern (ST/mST). All analyses were performed in Stata 12 
(StataCorp, College Station, Texas, USA). 
 
Results 
A total of 22,246 samples (9,747 pooled faeces samples, 10,905 individual faeces 
samples and 1,594 environmental samples) were collected from farm visits conducted 
between April 2014 and May 2016. The initial visit (visit 1) results demonstrated a 
similar high prevalence of Salmonella from faeces samples in both vaccine and control 
groups; 30.8% vs 36.2% of pooled samples, 19.1% vs 21.9% of individual samples, and 
34.6% vs 53.0% of environmental samples, for vaccine and control groups respectively 
(Table 1). Clinical problems associated with Salmonella infections were reported from 
six vaccine and three control farms respectively at visit 1.  
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Table 1. Results from the pooled and individual faecal samples and environmental samples collected for 
the evaluation of the protection against Salmonella Typhimurium and its monophasic variants conferred 
by a vaccine administered to sows on eight pig herds and compared to eight control farms. Salmonella 
vaccination commenced between the first and second visit (N: total number of samples.) 
Salmonella-positive 
Visit  
Pooled samples Individual samples Environmental samples 
Vaccine Control Vaccine Control Vaccine Control 
N % N % N % N % N % N % 
1 1,297 30.8 1,169 36.2 1,430 19.1 1,062 21.9 238 34.6 160 53.0 
2 1,268 28.2 1,240 32.0 1,429 20.0 1,382 26.9 201 29.2 159 47.4 
3 1,279 26.1 1,178 31.4 1,394 20.6 1,360 26.8 188 31.3 228 40.6 
4 1,288 19.8 1,028 41.0 1,423 13.4 1,425 32.0 208 21.2 212 42.8 
S. Typhimurium and monophasic variants -positive 
Visit  
Pooled samples Individual samples Environmental samples 
Vaccine Control Vaccine Control Vaccine Control 
N % N % N % N % N % N % 
1 1,297 26.6 1,169 31.3 1,430 17.8 1,062 21.7 238 30.1 160 46.3 
2 1,268 26.4 1,240 26.0 1,429 19.5 1,382 23.2 201 28.7 159 40.8 
3 1,279 24.2 1,178 27.8 1,394 18.7 1,360 23.8 188 27.2 228 36.6 
4 1,288 19.1 1,028 34.3 1,423 13.2 1,425 27.0 208 20.6 212 35.8 
 
At the second and third visits, following the start of the vaccination programme, 
reduction in prevalence of Salmonella and ST/mST was not apparent in control farms. 
However, vaccine farms showed sustained reduction of Salmonella prevalence up to the 
final visit. In addition, a higher proportion of vaccine farms (5 farms out of 6) resolved 
clinical salmonellosis than control farms (2 of 3). The effect of vaccination was not 
consistent on all farms; in one farm prevalence increased at visit 2 and this rise was 
sustained up to the final visit for both pooled samples and individual samples. Another 
vaccine farm showed only a slight reduction after vaccination, with a similar sample 
prevalence observed at visits 2 and 3 to that at visit 1. The results of Salmonella 
enumeration in positive faecal samples showed no apparent significant effect of 
vaccination. 
The mixed-effects models showed a significantly decreased odds ratio of 
Salmonella-positive (Odds Ratio (OR) = 0.73, p<0.001) and ST/mST-positive samples 
(OR = 0.71, P<0.001) for vaccine farms in comparison to control farms and that 
samples collected at visit 2 where at significantly lower odds for both outcomes than at 
the first visit. Examining the interaction between the experimental groups and visit 
number showed there was a significantly decreased odds of Salmonella-positive (OR = 
0.51, p<0.001) or ST/mST-positive (OR = 0.61, p<0.001) at visit 4 for vaccine farms 
only. The inclusion of the a priori variables accounted for a significantly increased odds 
of isolation of Salmonella and ST/mST in pooled samples. There was a significantly 
increased odds of isolation in summer of Salmonella and ST/mST and an increase in 
spring and autumn for ST/mST-positive when compared with winter. Finally, the model 
showed significantly increased odds of Salmonella-positive and ST/mST-positive 
samples for all pig group types (except boars) and significantly reduced odds for 
farrowing groups, when compared against the gestation group. 
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Conclusion 
The significant results of the mixed-effects model have demonstrated that the 
strategy of maternal vaccination against ST is able to reduce, in a substantial proportion 
of treated farms, both faecal and environmental prevalence of Salmonella in farrow-to-
finish pig herds. Although a beneficial association between vaccination and Salmonella 
reduction was observed, vaccination strategies alone were not sufficient to eliminate 
infection and vaccines should preferably be applied to uninfected animals on a 
preventative basis rather than in the face in infection [6].  
Vaccinal protection of sows is particularly relevant in farrow-to-finish pig herds 
where breeders and finishers are housed in the same environment and weaned pigs 
present a continuous source of environmental contamination with ST or mST. Once all 
sows were vaccinated a reduction in Salmonella prevalence was observed in all stages 
of pig production, and mainly in finishers, hence reducing the Salmonella burden before 
slaughter. Previous findings have also shown that pigs born from vaccinated sows have 
reduced Salmonella faecal shedding and that the effect on environmental contamination 
and re-cycling of infection is also important [4].  
However, the Salmonella prevalence reduction observed in the vaccinated farms 
was not observed in all herds, and this is consistent with other studies. De Ridder et al 
[7] observed response variability after oral vaccinated of piglets with the same product 
on three farrow-to-finish pig herds. In our study, vaccination did not have a marked 
effect on two herds which had clinical salmonellosis reported before the start of 
vaccination, which may have represented a recent outbreak caused by a new strain and 
presenting an overwhelming challenge for the vaccine within the timescale of the study. 
Our results provide evidence that maternal vaccination on a farrow-to-finish pig herd 
was a suitable ST/ mST reduction strategy and helped to control clinical salmonellosis. 
Salmonella vaccines therefore have the potential to reduce prevalence of Salmonella in 
pigs and result in a reduction of human cases. 
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